Rivka Yatuv

514 total citations
14 papers, 378 citations indexed

About

Rivka Yatuv is a scholar working on Hematology, Genetics and Genetics. According to data from OpenAlex, Rivka Yatuv has authored 14 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 5 papers in Genetics and 3 papers in Genetics. Recurrent topics in Rivka Yatuv's work include Platelet Disorders and Treatments (7 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Hemophilia Treatment and Research (4 papers). Rivka Yatuv is often cited by papers focused on Platelet Disorders and Treatments (7 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Hemophilia Treatment and Research (4 papers). Rivka Yatuv collaborates with scholars based in Israel, Russia and Japan. Rivka Yatuv's co-authors include Uri Seligsohn, Ariella Zivelin, Hava Peretz, Nurit Rosenberg, Moshe Baru, Angela Chetrit, Frédéric Bauduer, Rima Dardik, V. M. Sobolev and Abraham Danon and has published in prestigious journals such as Blood, Journal of Controlled Release and Expert Opinion on Drug Delivery.

In The Last Decade

Rivka Yatuv

13 papers receiving 376 citations

Peers

Countries citing papers authored by Rivka Yatuv

Since Specialization

Citations

This map shows the geographic impact of Rivka Yatuv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rivka Yatuv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rivka Yatuv more than expected).

Fields of papers citing papers by Rivka Yatuv

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rivka Yatuv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rivka Yatuv. The network helps show where Rivka Yatuv may publish in the future.

Co-authorship network of co-authors of Rivka Yatuv

This figure shows the co-authorship network connecting the top 25 collaborators of Rivka Yatuv. A scholar is included among the top collaborators of Rivka Yatuv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rivka Yatuv. Rivka Yatuv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	A novel red grape cells complex: health effects and bioavailability of natural resveratrol 2014 ·International Journal of Food Sciences and Nutrition ·(unknown), Rivka Yatuv, (unknown), (unknown), Abraham Danon	16
2	Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII – an open label, exploratory, cross‐over, phase I/II study 2010 ·Haemophilia ·Jack Spira, (unknown), (unknown), Rivka Yatuv, (unknown), (unknown), (unknown), Moshe Baru	15
3	Enhancement of the efficacy of therapeutic proteins by formulation with PEGylated liposomes; a case of FVIII, FVIIa and G-CSF 2010 ·Expert Opinion on Drug Delivery ·Rivka Yatuv, (unknown), (unknown), Moshe Baru	12
4	Binding of proteins to PEGylated liposomes and improvement of G-CSF efficacy in mobilization of hematopoietic stem cells 2008 ·Journal of Controlled Release ·Rivka Yatuv, (unknown), (unknown), (unknown), Moshe Baru	12
5	Enhancement of factor VIIa haemostatic efficacy by formulation with PEGylated liposomes 2008 ·Haemophilia ·Rivka Yatuv, (unknown), (unknown), (unknown), (unknown), (unknown), Moshe Baru	26
6	A modified chromogenic assay for the measurement of very low levels of factor VIII activity (FVIII:C) 2006 ·Haemophilia ·Rivka Yatuv, (unknown), Moshe Baru	8
7	Major mutations in calf-1 and calf-2 domains of glycoprotein IIb in patients with Glanzmann thrombasthenia enable GPIIb/IIIa complex formation, but impair its transport from the endoplasmic reticulum to the Golgi apparatus 2003 ·Blood ·Nurit Rosenberg, Rivka Yatuv, V. M. Sobolev, Hava Peretz, Ariella Zivelin, Uri Seligsohn	31
8	Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene 2002 ·Blood ·Ariella Zivelin, Frédéric Bauduer, (unknown), Hava Peretz, Nurit Rosenberg, Rivka Yatuv, Uri Seligsohn	81
9	Identification of a region in glycoprotein IIIa involved in subunit association with glycoprotein IIb: further lessons from Iraqi-Jewish Glanzmann thrombasthenia 2001 ·Blood ·Rivka Yatuv, Nurit Rosenberg, Ariella Zivelin, Hava Peretz, Rima Dardik, (unknown), Uri Seligsohn	20
10	Glanzmann thrombasthenia in two Iraqi-Jewish siblings is caused by a novel splice junction mutation in the glycoprotein IIb 1998 ·Blood Coagulation & Fibrinolysis ·Rivka Yatuv, Nurit Rosenberg, Rima Dardik, Barry M. Brenner, Uri Seligsohn	10
11	Glanzmann Thrombasthenia Caused by an 11.2-kb Deletion in the Glycoprotein IIIa (β3 ) Is a Second Mutation in Iraqi Jews That Stemmed From a Distinct Founder 1997 ·Blood ·Nurit Rosenberg, Rivka Yatuv, (unknown), Ariella Zivelin, Rima Dardik, Hava Peretz, Uri Seligsohn	0
12	Glanzmann Thrombasthenia Caused by an 11.2-kb Deletion in the Glycoprotein IIIa (β3 ) Is a Second Mutation in Iraqi Jews That Stemmed From a Distinct Founder 1997 ·Blood ·Nurit Rosenberg, Rivka Yatuv, (unknown), Ariella Zivelin, Rima Dardik, Hava Peretz, Uri Seligsohn	33
13	One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews [see comments] 1995 ·Blood ·(unknown), Hava Peretz, Ariella Zivelin, Rivka Yatuv, Angela Chetrit, (unknown), (unknown), (unknown), Uri Seligsohn	4
14	One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews [see comments] 1995 ·Blood ·(unknown), Hava Peretz, Ariella Zivelin, Rivka Yatuv, Angela Chetrit, (unknown), (unknown), (unknown), Uri Seligsohn	110

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact